Skip to Content
Søg Menu
Vi dækker

ECTRIMS | European Committee for Treatment and Research in Multiple Sclerosis

Webinar: NMOSD – Clinical Insights and Recent Advances 

Join the webinar on advances in immunotherapy for NMOSD, MOGAD, and autoimmune encephalitis. Discover new data from ECTRIMS 2025, immunopathological insights, and future treatment perspectives.

ECTRIMS 2025

ECTRIMS 2024

Sahla El Mahdaoui

The effects of anti-CD20 therapy on TFH cells in relapsing-remitting MS

/ Sahla El Mahdaoui
ECTRIMS24MS Play the Video

ECTRIMS 2024: New Data Has the Potential to Paving the Way for More Personalised and Effective Treatment Plans

/ Jan Andreasen
ECTRIMS24MS

Top 4 mest sete MEDtalks fra ECTRIMS 2024

DMTs During Pregnancy in Women with MS Do Not Affect Relapse Rates in Postpartum Periods

/ Neurologi / Lene Von Kappelgaard

Poor Sleep Has a Deleterious Impact on Health-Related Quality of Life in People with MS

/ Neurologi / Martin Langeskov Christensen

New Biomarker and Comorbidity Insights in NMOSD and MOGAD

/ Neurologi / Nasrin Asgari

Nationwide Patient-Reported Outcome Portal for MS is Feasible and Provides Clinical Value

/ Neurologi / Rolf Pringler Holm

Lina Moschoula Passali

MS: This increase in Blood-Brain Barrier Permeability Appears to be Connected to the Spread of Lesions Across the Brain

/ Lina Moschoula Passali
ECTRIMS24MS Play the Video

Oceans of Hope Project Gives Patients with MS Higher Quality of Life

/ Mikkel Anthonisen
ECTRIMS24MS Play the Video
Ulrik Dalgas

Exercise is Essential for Maximizing Cognitive and Physical Functions for Individuals with MS

/ Ulrik Dalgas
ECTRIMS24MS Play the Video
Lars Hvid

Tværfaglig rehabilitering giver positive langtidseffekter mod fatigue hos personer med MS

/ Lars Hvid
ECTRIMS24MS Play the Video
Marie Lynning

Low Health Literacy is Associated with Lower Levels of Education, Progressive Disease Types and Higher Disease Severity in MS

/ Marie Lynning
ECTRIMS24MS Play the Video
Melinda Magyari

Patients with Secondary Progressive MS Have a Higher Mortality than Those with Primary Progressive MS

/ Melinda Magyari
ECTRIMS24MS Play the Video

Earlier Access to Effective Treatments for Children with MS Reduces the Burden of Long-Term Disability

/ Jan Andreasen
ECTRIMS24MS

ECTRIMS 2024: The World’s Largest MS Congress in Copenhagen 

/ BestPractice Nordic
ECTRIMS24MS

Ublituximab, direkte indplaceret i behandlingsvejledning – bakkes op af nye data ved ECTRIMS24

/ Jan Andreasen
ECTRIMS24MS
Back to top